Comparing Efficacy of Optimal Treatment and Conventional Treatment for Major Depressive Disorder in Viet Nam
NCT04826614 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 171
Last updated 2023-08-29
Summary
Comparison of efficacy treatment (respond, remission) between the optimized treatment group (dose adjustment or early change other drug based on the change of total score HAM-D 17) and the routine treatment group (start with the lowest effective dose and adjust dose slowly) for depressed patients in Viet Nam
Conditions
Interventions
- OTHER
-
optimized treatment
early adjust dose or change drug
Sponsors & Collaborators
-
University of Medicine and Pharmacy at Ho Chi Minh City
lead OTHER
Principal Investigators
-
Dung V Do · Ho Chi Minh University of Medicine and Pharmacy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2022-07-30
- Completion
- 2023-07-30
Countries
- Vietnam
Study Locations
More Related Trials
-
Antidepressant Decision Aid for Major Depressive Disorder Patients
NCT04761757 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
NCT06692361 ·Status: RECRUITING ·Phase: NA
-
Clinical Trial of Memantine for Major Depression
NCT00040261 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
NCT01632267 ·Status: COMPLETED
-
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
NCT00817375 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder
NCT02272517 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Levomilnacipran in Geriatric Depression
NCT02466958 ·Status: COMPLETED ·Phase: PHASE4
-
Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)
NCT00610649 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)
NCT00048607 ·Status: COMPLETED ·Phase: PHASE3
-
rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure
NCT00437827 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder
NCT01255787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
NCT00593879 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)
NCT00048594 ·Status: COMPLETED ·Phase: PHASE3
-
Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
NCT02046564 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD
NCT00785434 ·Status: COMPLETED ·Phase: PHASE4
-
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
NCT05017311 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
NCT01163266 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
NCT03785652 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
NCT04469322 ·Status: COMPLETED ·Phase: NA
-
A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression
NCT01098240 ·Status: TERMINATED ·Phase: PHASE2
-
Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
NCT05389046 ·Status: RECRUITING ·Phase: NA
-
The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
NCT04984512 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients
NCT01352572 ·Status: UNKNOWN ·Phase: NA
-
This is a Study to Determine the Antidepressant Effects of AZD6765
NCT00986479 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing Electroconvulsive Therapy for Depression
NCT00045916 ·Status: COMPLETED ·Phase: PHASE4